Offered by: Nemours Children's Specialty Care, Jacksonville
Location: Jacksonville, Fla.
Phase I Traditional 3+3 Trial of PO Sorafenib in Refractory or Recurrent Pediatric Solid Malignancies
What is the trial about?
To establish the safest doses of Topotecan and Sorafenib when given together to children whose tumors have not responded to treatment or whose tumors have come back despite treatment.
Who can participate?
Age >3 years and ≤18 years of age at the time of study entry.
What is involved?
Length of study is 24 months. Standard cancer care procedures.
Contact Nemours Clinical Trials
Trial Name: Phase I Traditional 3+3 Trial of PO Sorafenib in Refractory or Recurrent Pediatric Solid Malignancies